Brain MRI markers and dropout in a longitudinal study of cognitive aging: The Three-City Dijon Study

Neurology

Volumn 79, Issue 13, 2012, Pages 1340-1348

  Glymour, M Maria ^a   Chěne, Geneviève ^b,c,d   Tzourio, Christophe ^b,c,d   Dufouil, Carole ^b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; BRAIN DAMAGE; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITION; DEMENTIA; FEMALE; FOLLOW UP; FRANCE; HIPPOCAMPUS; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; WHITE MATTER;

EID: 84867539008     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826cd62a     Document Type: Article

References (41)

1. Chatfield MD, Brayne CE, Matthews FE. A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. J Clin Epidemiol 2005;58:13-19.
2. Vega S, Benito-León J, Bermejo-Pareja F, et al. Several factors influenced attrition in a population-based elderly cohort: neurological disorders in Central Spain Study. J Clin Epidemiol 2010;63:215-222.
3. Little RJ, Rubin DB. Statistical Analysis with Missing Data, 2nd ed. Hoboken, NJ: Wiley; 2002.
4. Dufouil C, Brayne C, Clayton D. Analysis of longitudinal studies with death and drop-out: a case study. Stat Med 2004;23:2215-2226.
5. Weuve J, Tchetgen Tchetgen E, Glymour MM, et al. Accounting for bias due to selective attrition in analyses of cognitive decline: the example of smoking and cognitive decline in older adults. Epidemiology 2012;23:119-128.
6. Glymour MM, Weuve J, Fay ME, Glass TA, Berkman LF. Social ties and cognitive recovery after stroke: does social integration promote cognitive resilience? Neuroepidemiology 2008;31:10-20.
7. Singh Manoux A, Marmot MG, Glymour M, Sabia S, Kivimaki M, Dugravot A. Does cognitive reserve shape cognitive decline? Ann Neurol 2011;70:296-304.
8. Morris MC, Evans DAMD, Hebert LE, Bienias JL. Methodological issues in the study of cognitive decline. Am J Epidemiol 1999;149:789-793.
9. Dufouil C, Alperovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology 2003;60:831- 836.
10. Manly JJ, Jacobs DM, Sano M, et al. Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. J Int Neuropsychol Soc 1999;5: 191-202.
11. Lezak MD. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press; 1995.
12. Dufouil C, Godin O, Chalmers J, et al. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009;40:2219-2221.
13. Godin O, Tzourio C, Rouaud O, et al. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study. J Alzheimers Disease 2010;20:453- 463.
14. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224-232.
15. Kramer JH, Mungas D, Reed BR, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007;21:412-418.
16. Debette S, Markus H. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. BMJ 2010;341:c3666.
17. Jack C Jr., Shiung M, Gunter J, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591-600.
18. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22: 316-325.
19. Maillard P, Delcroix N, Crivello F, et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases Neuroradiology 2008;50:31- 42.
20. Montlahuc C, Soumare A, Dufouil C, et al. Self-rated health and risk of incident dementia. Neurology 2011;77: 1457-1464.
21. Radloff LS. The Ces-D scale. Appl Psychol Meas 1977;1: 385-401.
22. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
23. Isaacs B, Kennie A. The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-470.
24. Benton A. Manuel Pour l'Application du Test de Re'tention Visuelle, 2nd ed. Paris: Centre de Psychologie Applique ́e; 1965.
25. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 1975;12:189-198.
27. Wang C, Hall CB. Correction of bias from non-random missing longitudinal data using auxiliary information. Stat Med 2010;29:671- 679.
28. Tyas SL, Tate RB, Wooldrage K, Manfreda J, Strain LA. Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data. Ann Epidemiol 2006;16:477- 484.
29. Brayne C, Spiegelhalter DJ, Dufouil C, et al. Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc 1999;47:1283-1288.
30. Euser SM, Schram MT, Hofman A, Westendorp RGJ, Breteler M. Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology 2008;19:440-447.
31. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol 2005;62:1545.
32. Herna'n MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004;15:615- 625.
33. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461- 468.
34. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000;56:779-788.
35. Robins JM, Rotnitzky A. Semiparametric efficiency in multivariate regression-models with missing data. J Am Stat Assoc 1995;90:122-129.
36. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics 2002;58:21-29.
37. Zhang JL, Rubin DB. Estimation of causal effects via principal stratification when some outcomes are truncated by "death." J Educ Behav Stat 2003;28:353.
38. Pavlik VN, de Moraes SA, Szklo M, Knopman DS, Mosley TH, Hyman PJ. Relation between cognitive function and mortality in middle-Aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003;157:327-334.
39. Nybo H, Petersen HC, Gaist D, et al. Predictors of mortality in 2,249 nonagenarians: the Danish 1905-Cohort Survey. J Am Geriatr Soc 2003;51:1365-1373.
40. Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in the community-dwelling elderly. Am J Epidemiol 2000;151:676-688.
41. Lo RY, Jagust WJ. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology 2012; 78:1376-1382.